At the forefront of pharmaceutical innovation, Virupaksha stands out for its unwavering commitment to delivering excellence in manufacturing high-purity Fluconazole, a critical medication in the fight against cryptococcal meningitis. With certifications that underscore their dedication to quality and safety—such as WHO-GMP compliance and ISO 9001 for superior quality management systems alongside ISO 14001 for environmental stewardship—Virupaksha ensures that every batch produced meets stringent global standards. 

 

Their state-of-the-art facilities are meticulously designed to uphold these standards, utilizing advanced technologies that enable precise control over production processes while minimizing environmental impact. This relentless pursuit of excellence not only reinforces their reputation as a trusted partner in healthcare but also significantly contributes to improving patient outcomes across diverse populations afflicted by this serious fungal infection.

Other Latest News